Good point - I never really thought of it in that
Post# of 72430
http://www.ipharminc.com/press-release/2017/3...ncer-agent
Final sentence in paragraph 5:
"Remaining safety studies will be completed in the second half of this year."
The PR in itself is pretty robust and informs us that things look good. So I guess you could be right.
Maybe we will hear about a Bridge Study next.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)